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effect of hyperglycemia on 
Purinergic and nitrergic inhibitory 
neuromuscular Transmission in the 
antrum of the stomach: implications 
for Fast gastric emptying
Xue-Dao He, Yan-Mei Guo and Raj K. Goyal*
Department of Medicine VA Boston Healthcare System, Harvard Medical School, Boston, MA, United States
Background: Hyperglycemia has been reported to enhance vagovagal reflex that 
causes the release of inhibitory neurotransmitter, nitric oxide (NO), at the neuromuscular 
junction in the antrum to relax the antrum and slow gastric emptying by stimulating 
glucose-sensitive afferent neurons. However, hyperglycemia has also been reported to 
cause fast gastric emptying that may be due to suppression of the inhibitory motor 
neurons.
aims: The purpose of the present study was to investigate changes in inhibitory neuro-
muscular transmission in the gastric antrum due to hyperglycemia.
Methods: Inhibitory electrical junction potentials were recorded from gastric antral 
muscle strips, using intracellular electrodes under non-adrenergic, non-cholinergic 
conditions. Studies were performed in non-hyperglycemic NOD (NH-NOD), NOD mice 
as they develop hyperglycemia (H-NOD) and their age-matched controls. The purinergic 
inhibitory junction potential (pIJP) and nitrergic IJP (nIJP) were isolated pharmacologically.
results: The control pIJP was large, around −18 mV and nIJP was small, around −9 mV. 
In NH-NOD the IJPs were not affected, but in H-NOD pIJP was nearly abolished and 
nIJP was significantly reduced. In H-NOD mice, membrane hyperpolarization caused by 
exogenous α,β-MeATP or diethylenetriamine NO adduct was similar to that in wild-type 
controls (P > 0.05). H-NOD smooth muscles were significantly depolarized as compared 
to NH-NOD smooth muscles.
conclusion: These observations show that hyperglycemia causes suppression of puri-
nergic and nitrergic transmission by acting on the motor neurons that form the last neuron 
in the vagovagal circuit. Moreover, the loss the neurotransmission is due to a defect in 
neurotransmitter release rather than a defect in signal transduction. Hyperglycemia also 
causes depolarization of smooth muscles that may increase their excitability.
Keywords: fast gastric emptying, slow gastric emptying, vagovagal reflexes, neuromuscular transmission, 
diabetic stomach
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inTrODUcTiOn
Vagus nerve and myenteric plexus play a central role in the 
regulation of gastric motility and gastric emptying (1). The 
neural circuits that mediate vagovagal reflexes include vagal 
afferents with their cell bodies located in the nodose ganglion 
and their centrally projecting fibers found in the nucleus tractus 
solitarius, that synapse on neurons in the dorsal motor nucleus 
of the vagus (DMV). The DMV houses preganglionic neurons 
for parallel excitatory and inhibitory pathways, that synapse 
with excitatory and inhibitory postganglionic motor neurons, 
respectively, located in the myenteric plexus in the stomach. 
The postganglionic vagal neurons are shared with the myenteric 
motor neurons and are also connected with other myenteric 
neurons, including the intrinsic afferent neurons. The myenteric 
plexus mediates local intragastric reflexes that integrate activities 
of different parts of the stomach that is required for gastric motil-
ity and gastric emptying. The vagal postganglionic/myenteric 
inhibitory and excitatory neurons are final components of the 
vagovagal or local myenteric plexus circuits. The main inhibitory 
neurotransmitters are nitrergic [nitric oxide (NO)], purinergic, 
and peptidergic (VIP) in nature, and the main excitatory trans-
mitter is cholinergic (2, 3).
Several studies have shown that gastric fundus and proximal 
corpus constitute the pressure pump and is involved in gastric 
emptying of liquids and solids and distal corpus and antrum con-
stitute the peristaltic pump and is particularly involved in gastric 
emptying of solids but also liquid chyme. Pylorus acts as a grinder 
and regulates gastric emptying of solids (4, 5). Hyperglycemia is 
considered to delay gastric emptying, both in healthy controls 
and in patients with diabetes mellitus (6). However, parenteral 
hyperglycemia has been shown to produce variable effects on 
gastric emptying rates, depending on the nature of the meal (7). 
Hyperglycemia-induced slow gastric emptying is due to gastric 
relaxation and reduced antral contractions (8, 9). Hyperglycemia 
is reported to cause gastric relaxation and reduced antral contrac-
tions induced by insulin hypoglycemia by a central action on the 
nuclei of vagal afferents (10).
The vagovagal reflex that induces gastric relaxation and slow 
gastric emptying involve stimulation of the vagal afferents at 
their origin at the gastro-duodenal mucosa (11). These afferents 
have glucose-stimulated neurons (12, 13). The motor arm of this 
reflex involves vagal efferent cholinergic preganglionic neurons 
synapsing on intragastric NO-containing neurons to mediate 
gastric relaxation that causes slow gastric emptying (11, 14). 
Hyperglycemia enhances this reflex by depolarizing the glucose-
stimulated afferent neurons by closing KATP potassium channels 
(15). Therefore, hyperglycemia causes an increase in gastric 
compliance and postprandial relaxation (9), a fall in intragastric 
pressure, reduction in “peristaltic” contractions in the corpus 
and the antrum, leading to a slow gastric emptying (6). However, 
there have been reports that hyperglycemia may be associated 
with fast gastric emptying in experimental animals (16–18). For 
example, Frank (19) reported that in NIDDM, hyperglycemia 
causes faster emptying of liquids associated with more significant 
phasic contractions in the proximal stomach. The site of action 
of hyperglycemia-induced fast gastric emptying is not known. 
It was possible that hyperglycemia may act peripherally on 
the postganglionic/myenteric inhibitory motor neuron of the 
vagovagal circuit or inhibitory neuromuscular transmission 
(NMT) to affect fast gastric emptying.
Hyperglycemia has also been reported to induce aberrations 
in the antral slow waves, such as tachygastria and uncoupling of 
slow waves, associated with suppression of nitrergic neurotrans-
mission to the ICC that may cause slow gastric emptying (20–22).
Purpose of the present studies was to examine the direct effect 
of hyperglycemia, distinct from that of other complications of 
diabetes, on inhibitory NMT. We used a model of endogenous 
subacute hyperglycemia that distinguishes it from the effect of 
acute hyperglycemia produced by administration of high glucose 
and from chronic hyperglycemia that may be associated with 
long-term complications such as oxidative stress (16). All NOD 
mice show fast gastric emptying in the first few weeks, but a 
small number develop slow gastric emptying on a more extended 
period of follow-up (16) NOD mice develop insulin-dependent 
diabetes mellitus due to inflammatory destruction of beta cells 
in the pancreas. In order to determine whether the changes in 
the NOD mice were due to hyperglycemia and not due to the 
inflammatory phenotype of the NOD mice were compared any 
changes in hyperglycemic NOD (H-NOD) mice with those in 
non-hyperglycemic NOD (NH-NOD) mice.
The inhibitory motor neurons act by releasing not only a 
nitrergic neurotransmitter but also a purinergic neurotransmitter 
(2, 3). Therefore, we examined: (1) the effect hyperglycemia on 
both nitrergic purinergic inhibitory NMT in the gastric antrum; 
(2) whether the loss of purinergic and nitrergic neurotransmis-
sions was due to loss of neurotransmitter release or a defect in 
signal transduction; and (3) whether inhibitory NMT was unaf-
fected in NH-NOD mice.
MaTerials anD MeThODs
ethical
The study protocol was conducted according to the Guide 
for the Care and Use of Laboratory Animals of the NIH and 
approved by the Institutional Animal Care and Use Committee 
of VA Boston Healthcare System (IACUC #357-W-050415 and 
IACUC#101-W-063012).
animals
All animals were obtained from Jackson Laboratory (Bar Harbor, 
ME, USA). Female C57BL/6J wild-type (WT) mice served as 
controls. Female NOD mice (NOD/shiLtJ; number 001976) 
10-week old were used as models of diabetes. This strain is a 
widely used model diabetic stomach associated with type-1 
diabetes (16). Development of hyperglycemia (diabetes) is more 
frequently in females NOD mice, and increase with age (23).
NOD mice were tested for glycosuria and blood glucose 
level. Glycosuria was tested with Clinistix reagent strips for uri-
nalysis (Bayer Corporation, Elkhart, IN, USA) and graded semi-
quantitatively. Random blood glucose levels were determined by 
tail-vein sampling with the ACCU-CHECK complete diabetes-
monitoring Kit (model 200, Roche Diagnostics Corporation, 
TaBle 1 | Background data.
WT1 nh-nOD WT2 h-nOD
N 10 10 10 10
Sex F F F F
Age (week) 14.4 ± 0.7 (12–25) 14.6 ± 0.5 (12–25) 26.8 ± 5.5 (13–47) 27.0 ± 5.5 (13–47)
Weight (g) 21.0 ± 0.7 (19–28) 21.8 ± 0.6 (20–28) 24.2 ± 1.1 (23–34) 16.4 ± 0.5* (15–18)
Blood sugar (mg/dl) 155.4 ± 2.0 (135–159) 158.6 ± 1.2 (151–159) 156.6 ± 2.0 (148–159) 284.6 ± 3.3** (255–390)
*P < 0.001.
**P < 0.001.
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Indianapolis, IN, USA). Blood glucose levels below 160  mg/dl 
were labeled as NH-NOD. Blood glucose levels over 250  mg/
dl were labeled H-NOD. When the blood glucose rose above 
350  mg/dl, the mice were treated with sub-therapeutic insulin 
(Humulin 50/50, Eli Lilly and Company, Indianapolis, IN, USA), 
injected twice daily subcutaneously, to avoid fatality.
chemicals
The Krebs solution contained (in mM) NaCl 115.4, KCl 4.6, 
CaCl2⋅2H2O 2.5, MgCl2⋅2H2O 1.2, dextrose 11.5, NaHCO3 21.9 
and NaH2PO4⋅2H2O 1.2, and bubbled with a mixture of 5% 
CO2–95% O2 (pH 7.4). Apamine, atropine, guanethidine, nifedi-
pine, α,β-methyleneadenosine 5′-triphosphate(α,β-MeATP), 
Nω-nitro-l-arginine methyl ester hydrochloride, l-NAME 
hydrochloride, and diethylenetriamine nitric oxide adduct 
[DETA-NO (DNO)] were obtained from Sigma Chemical (St. 
Louis, MO, USA). (1R*,2S*)-4-[2-Chloro-6-(methylamino)-9H-
purin-9-yl]-2-phosphornooxybicycle[3.1.0]hexane-1-methanol 
dihydrogen phosphate ester di-ammonium salt (MRS-2279) was 
obtained from Tocris Biosciences (Ellisville, MO, USA).
intracellular recording
Gastric antrum was removed, and circular muscle strips were 
prepared. Intracellular recordings of membrane potential were 
obtained from the smooth muscle cells, using microelectrodes 
made from glass of 1.2 mm OD × 0.6 mm ID with Omega Dot 
fiber and filled with 3 M KCl. The resistance of the microelec-
trodes was between 30 and 80 MΩ as described earlier (3). All 
membrane potential values were determined by the difference 
between the stable potential recorded within the cell compared 
with the balanced zero potential upon withdrawal, as described 
earlier (2, 3).
generation of the piJP and niJP
The muscle strips represented nerve-muscle preparations, as 
they contained myenteric plexus along with innervation of the 
muscles. Two Ag-AgCl electrodes (0.26 mm diameter) positioned 
above and below the preparation perpendicular to its longitu-
dinal axis, and 5  mm away from the recording microelectrode 
was used to deliver trans-mural stimulations. These electrodes 
were insulated up to 2 mm from their tips and connected to a 
stimulator (Grass S-88) in series with a stimulus isolation unit 
(Grass SIU5). Optimal stimulus parameters (70 V, 0.7–1 ms dura-
tion square pulses at 20 Hz for 0.5 s) were used. The perfusing 
solution contained atropine (1 µM) and guanethidine (5 µM) to 
create non-adrenergic, non-cholinergic (NANC) conditions. The 
perfusing solution also included nifedipine (0.1 µM) that reduced 
contraction of the muscle. We examined the IJPs in during the 
period when slow waves were absent. The compound inhibitory 
junction potentials (cIJPs) in the stomach can be resolved into a 
large amplitude fast purinergic IJP (pIJP) and a small amplitude 
slow nitrergic IJP (nIJP) components. We used perfusion with 
apamin (0.3  µM) or MRS-2279 (5  µM) to block the pIJP and 
l-nitro-l-arginine methyl ester (200 µM) to block the nIJP.
statistical analysis
All statistical evaluations were performed with Statistics software 
SPSS 21.0 (IBM). The data were expressed as the mean ± SD. For 
comparison between two data sets, a Student’s t-test was used. 
Analysis of differences between multiple groups of data was per-
formed with one-way ANOVA followed by a post hoc Bonferroni 
test. Differences were considered be significant at a P-value less 
than 0.05.
resUlTs
studies in nOD Mice Background Data
We divided the NOD mice into H-NOD mice and NH-NOD 
mice groups. C57BL/6J mice with matching age to the two groups 
were used as WT controls. Sex, age, and weight of the NH-NOD 
mice and matching WT-1; and H-NOD mice and matching WT-2 
are summarized in Table  1. Mice in all groups were females. 
Their weights were comparable except that the H-NOD mice had 
significantly lower weight than the other groups.
In the WT-1 controls for NH-NOD and the NH-NOD mice, 
random blood sugar levels were 155.4 ± 2.0 mg/dl (135–159 mg/
dl, n = 11) and 162.6 ± 1.2 mg/dl (160–166 mg/dl, n = 11). This 
difference was not significant (P = 0.09). In the WT-2 controls 
for H-NOD, random blood sugar levels were 155.6 ± 2.0 mg/dl 
(148–159 mg/dl, n = 11) and in the H-NOD mice, random blood 
sugar levels were 284.6 ± 3.2 mg/dl (255–390 mg/dl, n = 11). These 
values are significantly higher than their controls (P < 0.0001). 
Blood sugar levels in H-NOD mice were also significantly greater 
than in NH-NOD mice (P < 0.001).
resting Membrane Potential (rMP)
In the NH-NOD mice, RMP recorded from the smooth muscle 
cells was −51.7 ± 0.5 mV a value that was not different from that 
in the WT1 controls −51.5 ± 0.63 mV (P > 0.5, n = 18 cells in 
10 animals). In the H-NOD mice, the RMP was −48.4 ± 0.4 mV; 
these values are significantly lower than their WT2 controls 
FigUre 1 | Compound IJP in wild-type (WT) controls, non-hyperglycemic NOD (NH-NOD), and hyperglycemic NOD (H-NOD). Panel (a) shows actual examples 
and panel (B) shows cumulative data on the amplitudes of the compound IJP. Note that in WT controls, the compound IJP consist of overlapping fast and slow 
IJPs. The amplitude of the compound IJP is due to the fast IJP [peaking at around 1 s after the onset of electric field stimulus (EFS)]. In NH-NOD mice amplitude  
of the compound IJP was not affected. However, but in H-NOD the compound IJP was markedly suppressed, and that peaked at around 4 s after the onset of  
the EFS, suggesting that fast IJP may be obliterated the slow IJP suppressed. Values are mean ± SD. *P < 0.001.
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−55.0 ± 1.9 mV (P < 0.001, n = 18 cells in 10 animals) and the 
NH-NOD mice (P < 0.0001).
compound iJP
Under the NANC condition, the cIJP consists of two overlapping 
components, fast and slow IJPs. The fast IJP is large in amplitude 
and peaks at around 1  s, and the slow IJP is less than half the 
magnitude of the of the fast IJP peaks at around 4 s after the onset 
of the stimulus. The fast IJP provide the maximal amplitude of 
the compound IJP in the stomach (Figure  1). The amplitude 
of the compound IJP was 17.9 ± 0.5 mV in the WT-1 controls 
and NH-NOD it was 17.8 ± 0.2 mV (P = 0.8). In WT-2 control 
animals, the magnitude of the compound IJP was 19.5 ± 0.5 mV, 
and in H-NOD it was 3.4 ± 0.2 mV (P < 0.001). Interestingly, the 
peak amplitude of the compound IJP in WT-2 controls occurred 
at 1 s after the onset of the stimulus, but the peak amplitude in 
H-NOD took place at around 4 s after the start of the stimulus. 
These observations suggested that the peak amplitude of the 
compound IJP reflect the fast IJP and the peak amplitude of the 
reduced compound IJP in H-NOD indicated nearly lost fast IJP 
but suppressed slow IJP. The fast IJP is purinergic, and the slow 
IJP is nitrergic. Therefore, further studies were performed on 
chemically isolated pIJP and nIJPs.
The fast IJP of the compound IJP was blocked by apamin 
(0.3 µM), or by a selective inhibitor of P2y1 receptors, MRS-2279 
(5 µM) (24). On the other hand, the slow component was sup-
pressed by l-NAME, an inhibitor of NOS and represented nIJP. 
The potency order of the P2y1 antagonists is MRS-2500 > MRS-
2279 > MRS-2179 (25). However, pIJP was fully revealed after 
treatment with l-NAME and nIJP was fully revealed after treat-
ment with apamin or MRS-2279.
Purinergic iJP
The pIJP in NH-NOD and H-NOD and their respective controls 
are shown in Figure  2. The pIJP in the NH-NOD mice was 
17.8 ± 0.2 mV a value that was not different from 17.9 ± 0.5 mV 
in the WT-1 control (P > 0.05, n = 13 cells in 10 animals). In the 
H-NOD mice, pIJP was significantly reduced (97%) compared 
FigUre 2 | Purinergic IJP (pIJP) in wild-type (WT) controls, non-hyperglycemic NOD, and hyperglycemic NOD (H-NOD). Panel (a) shows actual examples and 
panel (B) shows cumulative data on the amplitudes of the pIJP. Note that the pIJP was unaltered as compared to the WT control but almost abolished in H-NOD 
mice. Values are mean ± SD. *P < 0.0001.
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with WT-2 controls (0.5 ±  0.1 vs. 19.5 ±  0.6 mV; P <  0.0001, 
n  =  18 cells in 10 animals), or compared with the value in 
NH-NOD mice 17.8 ± 0.2 mV (P < 0.0001).
hyperpolarization to α,β-MeaTP
To determine changes in responsiveness of the postjunctional 
apparatus to the purinergic neurotransmitter, we examined 
smooth muscle responses to purinergic receptor agonist α,β-
MeATP (26). Figure 3 shows membrane potential responses to 
exogenous α,β-MeATP in H-NOD, NH-NOD, and their respec-
tive controls. Exogenous α,β-MeATP caused hyperpolarization of 
10.2 ± 0.3 mV (n = 12 cells in 10 animals) in H-NOD, which has 
no difference compared with 10.2 ± 0.4 mV in WT2 controls (17 
cells from 10 animals; P > 0.5). In the NH-NOD mice, membrane 
hyperpolarization in α,β-MeATP (33 µM) was 9.9 ±  0.4 mV, a 
value very close to that in the WT1 10.4 ±  0.3 mV (P >  0.05, 
13 cells from 10 animals). Overall, these results suggest that the 
suppression of purinergic responses in the diabetic stomach is 
not due suppressed purinergic signal transduction in PDGFRα 
or smooth muscle cells (27).
nitrergic iJP
The nIJP was isolated by performing studies under NANC 
conditions and by blocking purinergic responses with P2y1 
receptor inhibitors MRS-2279. Figure 4 shows changes of nIJP 
in each group. In NH-NOD mice, nIJP was 9.2 ± 0.3 mV, value 
not different from 8.4 ±  0.8  mV in WT-1 controls (P >  0.05, 
n = 11 cells in 10 animals) showing that NH-NOD mice have no 
impaired nitrergic NMT. In the H-NOD mice nIJP was signifi-
cantly reduced by 58% as compared to that in their WT controls 
(3.4 ± 0.2 mV in H-NOD compared with 8.2 ± 0.3 mV in WT-2 
controls; P < 0.0001, n = 18 cells in 10 animals); and as compared 
the NH-NOD (P < 0.0001).
hyperpolarization to DnO
To determine the responsiveness of the postjunctional apparatus 
to the nitrergic neurotransmitter, we examined smooth muscle 
responses to nitrergic receptor agonist, DNO, a direct NO donor 
that interact with heme moiety of its intracellular receptor GTP-
cyclase (28). As shown in Figure 5, in the WT-1 control, DNO 
(660 µM) produced membrane hyperpolarization of 10.2 ± 0.5 mV, 
and it was 9.2 ± 0.6 mV in the NH-NOD mice. This difference was 
not significant (P > 0.05, n = 15 cells in 10 animals). In the H-NOD 
mice, membrane hyperpolarization evoked by DNO was 10.0 ± 0.4 
mV that was not different from that in WT-2 controls 10.4 ± 0.5 
mV (P > 0.05, n = 12 cells in 10 animals). Moreover, the values of 
DNO-induced hyperpolarization in NH-NOD 9.2 ± 0.6 mV and 
H-NOD 10.0 ± 0.4 mV were not significantly different (P > 0.5). 
FigUre 3 | Membrane hyperpolarization of purinergic agonist α,β-MeATP. Panel (a) shows actual examples and panel (B) shows cumulative data on the 
amplitudes of the purinergic inhibitory junction potential. Note that hyperpolarization to α,β-MeATP was no different in hyperglycemic NOD as compared to wild-type 
(WT) control.
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These observations show that postjunctional signal transduction 
evoked by DNO was not affected in NH-NOD or H-NOD mice.
DiscUssiOn
Fast gastric emptying is now increasingly recognized as a com-
plication of early diabetes and hyperglycemia in animal models 
of diabetes including NOD mice (16), leprdb/db mice (18) and 
streptozotocin-induced diabetes mellitus (17). Clinically also, 
diabetic patients with fast gastric emptying are being recognized 
with higher frequency even in well-established chronic diabetics. 
In one study of diabetic patients who underwent gastric emptying 
studies for clinical symptoms, fast gastric emptying was found to 
be fast in 22%, normal in 42%; and slow in 36% of the cases (29).
These studies show that inhibitory NMT, involving both 
purinergic and nitrergic neurotransmissions are suppressed in 
the gastric antrum during early stages of development of hyper-
glycemia in the NOD mice, suggesting that subacute hypergly-
cemia is the likely cause of these changes. Moreover, the effect of 
hyperglycemia was due to reduced transmitter release and not 
due to impaired signal transduction in the interstitial cells or 
smooth muscles. By suppressing inhibitory NMT in the gastric 
antrum, hyperglycemia may lead to fast gastric emptying.
An unexpected finding of our study was that purinergic 
neurotransmission was severely impaired by hyperglycemia. It is 
assumed that the purinergic NMT is preserved in the diabetic 
stomach because PDGFRα positive fibroblasts are preserved in 
the diabetic stomach (27). However, we found that the action 
of the purinergic neurotransmitter mimic was preserved 
hyper glycemia, suggesting that the loss of purinergic NMT in 
hyperglycemia was due to impaired neurotransmitter release. The 
importance of the loss of purinergic NMT is currently unknown 
(30). Studies in P2Y1 knock out mice may help define the role of 
purinergic NMT is gastric emptying (31).
The present study shows that nIJP is also impaired in the 
gastric antrum of subacutely H-NOD mice. The nIJP was reduced 
by almost 60% as compared with that of WT mice. Surprisingly, 
however, this reduction was less severe than that of the pIJP, 
which was nearly abolished. Impairment of nitrergic neuro-
transmission in acute or subacute hyperglycemia has not been 
reported before. Impaired nitrergic NMT of hyperglycemia may 
be due to impaired release of NO or impaired signal transduc-
tion of normally released NO or defective neural release of NO. 
There is a view that ICC-IM is required to transduce nitrergic 
neural signals to smooth muscles. However, this view has been 
questioned (32, 33). Moreover, any role for ICC in suppressing 
nitrergic NMT in hyperglycemia is unlikely because in acute or 
subacute hyperglycemia ICC are either not affected (34) or may 
even be increased (18). Moreover, the current studies show that 
DNO induced hyperpolarization was not impaired in subacutely 
H-NOD mice. All these observations suggest that defective 
inhibitory neurotransmission in the diabetic stomach was due to 
reduced transmitter release.
Hyperglycemia has been reported act on different targets to 
enhance gastric motility. It has been reported that hyperglycemia 
may increase ghrelin release that can enhance gastric empty-
ing (35). Hyperglycemia has also been reported to suppress 
the vagovagal reflex that is activated by cholecystokinin and 
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FigUre 4 | Nitrergic IJP (nIJP) in wild-type (WT) controls, non-hyperglycemic NOD (NH-NOD), and hyperglycemic NOD. Panel (a) shows actual examples and 
panel (B) shows cumulative data on the amplitudes of the nIJP. Note that in NH-NOD the nIJP was reduced to 40% of WT controls. Values are mean ± SD. 
*P < 0.0001.
secretin (12, 36). The motor pathway of this reflex involves the 
release of peptide VIP to cause gastric relaxation. Hyperglycemia 
antagonizes this reflex by hyperpolarizing the glucose-inhibited 
neurons in the afferent pathway by closing TWIK-related 
spinal cord potassium channels (36), resulting in antagonism 
of gastric relaxation that may lead to fast gastric emptying by 
hyperglycemia.
It has also been reported that hyperglycemic Leprdb/db mice 
with fast gastric emptying were reported to exhibit increased 
sensitivity to carbachol in causing contractions of the antral 
smooth muscle. The increased sensitivity of the smooth 
muscle was thought to be due to gain in the number of ICC 
in this model (18). However, increased excitability of smooth 
muscles is a well-established phenomenon in hyperglycemia 
(37). Consistent with the increased excitability of antral smooth 
muscle in hyperglycemia, we found that smooth muscles were 
depolarized in H-NOD mice. Loss of inhibitory NMT may con-
tribute to the smooth muscle excitability (37). Loss of inhibitory 
NMT and increased excitability of gastric fundus, corpus and 
antrum may lead to loss of compliance and enhanced contrac-
tions and accelerate gastric emptying. On the other hand, loss 
on the nitrergic inhibitory transmission is also known to cause 
delayed gastric emptying by causing loss of relaxation of the 
pyloric sphincter (38, 39). Further studies are needed to resolve 
this important paradox.
Hyperglycemia has been reported to stimulate mechanosensi-
tive vagal afferents of the vagovagal reflex that cause gastric relaxa-
tion and delayed gastric emptying by releasing inhibitory neurons 
at the neuromuscular junction (11, 15). However, as shown in the 
present study, hyperglycemia can act directly on the inhibitory 
motor neurons that are final mediators of the gastric inhibitory 
vagovagal circuits to suppress inhibitory NMT. Suppression of 
inhibitory NMT directly would nullify any stimulatory action of 
hyperglycemia on the afferent neurons that are upstream on the 
vagovagal circuit.
The mechanism of suppression of inhibitory neurotransmit-
ter release by hyperglycemia would require further studies. 
However, myosin-5a (Myo5a) dysfunction may be involved in 
hyperglycemia-induced suppression of the transmitter release. 
Subacute endogenous hyperglycemia in NOD mice is due to 
insulin deficiency. Insulin deficiency has been shown to cause 
the reduced function of AKT serine/threonine kinase 2 that sup-
presses the function of the intracellular motor, Myo5a. Reduced 
function of Myo5a suppresses membrane translocation of glucose 
transporter type 4 that reduces cellular glucose uptake (40). 
Reduced PI3/Akt signaling is seen in the diabetic stomach that is 
reversed by the glial cell-derived neurotrophic factor (41). It has 
been shown that Myo5a deficiency also causes loss of transport 
of the purinergic secretory vesicles and the enzyme nNOSα from 
the interior of varicosity to the plasma membrane where neuro-
transmitter release occurs and cause loss of neurotransmission 
(42–44). Moreover, Myo5a is reportedly reduced in nerves in the 
jejunum of diabetic rats (45). These observations suggest that 
Myo5a dysfunction due to insulin deficiency could be a common 
underlying factor in impaired purinergic and nitrergic NMT in 
H-NOD mice.
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